Health

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

November 04, 2024 02:00 ET | Source: Verona Pharma plc Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October…

3 weeks ago

OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the Treatment of Ulcerative Colitis

OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the…

3 weeks ago

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics

Germantown, Maryland, and Venlo, the Netherlands, Nov. 04, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today…

3 weeks ago

Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals

November 03, 2024 17:03 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals…

3 weeks ago

Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds

November 03, 2024 16:00 ET | Source: Belite Bio, Inc SAN DIEGO, Nov. 03, 2024 (GLOBE NEWSWIRE) -- Belite Bio,…

3 weeks ago

Optimal Breathing Holds its Annual Black Friday Sale

FORT MILL, S.C., Nov. 02, 2024 (GLOBE NEWSWIRE) -- Optimal Breathing will hold its annual Black Friday Sale online at…

3 weeks ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 01, 2024 19:04 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc.…

3 weeks ago

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 01, 2024 18:32 ET | Source: LENSAR, Inc. ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR)…

3 weeks ago

HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access

November 01, 2024 18:14 ET | Source: HeartFlow Holding, Inc. — Hospital Outpatient Prospective Payment System reimbursement rate doubled, expanding…

3 weeks ago

OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium

November 01, 2024 17:30 ET | Source: OnKure Therapeutics, Inc. OnKure to host a conference call to review key data…

3 weeks ago